Format

Send to

Choose Destination
Leuk Lymphoma. 2018 May;59(5):1030-1032. doi: 10.1080/10428194.2017.1382700. Epub 2017 Sep 27.

Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent?

Author information

1
a Department of Internal Medicine, School of Medicine , Yale University , New Haven , CT , USA.
2
b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University , New Haven , CT , USA.
PMID:
28952833
DOI:
10.1080/10428194.2017.1382700
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center